Cited by 529NF-κB Signaling PathwaysPI3K/AKT/mTOR signaling in cancerSignaling Pathways in Disease

Akt‐mediated regulation of NFκB and the essentialness of NFκB for the oncogenicity of PI3K and Akt

Open access
Bai, Dong, Ueno, Lynn, Vogt, Peter K.·2009·International Journal of Cancer

Abstract

The serine/threonine kinase Akt (cellular homolog of murine thymoma virus akt8 oncogene), also known as PKB (protein kinase B), is activated by lipid products of phosphatidylinositol 3‐kinase (PI3K). Akt phosphorylates numerous protein targets that control cell survival, proliferation and motility. Previous studies suggest that Akt regulates transcriptional activity of the nuclear factor‐κB (NFκB) by inducing phosphorylation and subsequent degradation of inhibitor of κB (IκB). We show here that NFκB‐driven transcription increases in chicken embryonic fibroblasts (CEF) transformed by myristylated Akt (myrAkt). Accordingly, both a dominant negative mutant of Akt and Akt inhibitors repress NFκB‐dependent transcription. The degradation of the IκB protein is strongly enhanced in Akt‐transformed cells, and the loss of NFκB activity by introduction of a super‐repressor of NFκB, IκBSR, interferes with PI3K‐ and Akt‐induced oncogenic transformation of CEF. The phosphorylation of the p65 subunit of NFκB at serine 534 is also upregulated in Akt‐transformed cells. Our data suggest that the stimulation of NFκB by Akt is dependent on the phosphorylation of p65 at S534, mediated by IKK (IκB kinase) α and β. Akt phosphorylates IKKα on T23, and this phosphorylation event is a prerequisite for the phosphorylation of p65 at S534 by IKKα and β. Our results demonstrate two separate functions of the IKK complex in NFκB activation in cells with constitutive Akt activity: the phosphorylation and consequent degradation of IκB and the phosphorylation of p65. The data further support the conclusion that NFκB activity is essential for PI3K‐ and Akt‐induced oncogenic transformation. © 2009 UICC

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/ijc.24748

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Activated NF-kB translocates to the nucleus and stimulates transcription of target genes, some of which include immune response genes and inflammasome components.

    “Activated NF-kB can then translocate to the nucleus, where it stimulates the transcription of its target genes, some of which include immune response genes and inflammasome components [88].”

    From Microglial function, INPP5D/SHIP1 signaling, and NLRP3 inflammasome activation: implications for Alzheimer’s disease (2023) · cites this paper as [88]

    The Introduction (page not provided) says that NFκB translocates to the nucleus, binds target-gene sites, and regulates transcription; it also links NFκB to innate and adaptive immune responses. Our copy does not identify inflammasome components as NFκB target genes, so that part of the attributed claim is unsupported. (LLM, conf=0.88)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 51

  1. [2]Okamoto T Sanda T Asamitsu K NF-kappa B signaling and carcinogenesis Curr Pharm Des 2007 13 447 62 17348842
  2. [4]Ito K Impact of post-translational modifications of proteins on the inflammatory process Biochem Soc Trans 2007 35 281 3 17371260
  3. [5]Kane LP Shapiro VS Stokoe D Weiss A Induction of NF-kappaB by the Akt/PKB kinase Curr Biol 1999 9 601 4 10359702
  4. [6]Sizemore N Leung S Stark GR Activation of phosphatidylinositol 3- kinase in response to interleukin-1 leads to phosphorylation and activation of the NF-kappaB p65/RelA subunit Mol Cell Biol 1999 19 4798 805 10373529 PMC84278
  5. [7]Romashkova JA Makarov SS NF-kappaB is a target of AKT in anti-apoptotic PDGF signalling Nature 1999 401 86 90 10485711
  6. [8]Gustin JA Ozes ON Akca H Pincheira R Mayo LD Li Q Guzman JR Korgaonkar CK Donner DB Cell type-specific expression of the IkappaB kinases determines the significance of phosphatidylinositol 3-kinase/Akt signaling to NF-kappa B activation J Biol Chem 2004 279 1615 20 14585846
  7. [9]Ozes ON Mayo LD Gustin JA Pfeffer SR Pfeffer LM Donner DB NF-kappaB activation by tumour necrosis factor requires the Akt serine-threonine kinase Nature 1999 401 82 5 10485710
  8. [10]Mercurio F Zhu H Murray BW Shevchenko A Bennett BL Li Jw Young DB Barbosa M Mann M Manning A Rao A IKK-1 and IKK-2: Cytokine-Activated I{kappa}B Kinases Essential for NF-B Activation Science 1997 278 860 6 9346484
  9. [11]Ling L Cao Z Goeddel DV NF-{kappa}B-inducing kinase activates IKK-{alpha} by phosphorylation of Ser-176 1998 95 3792 7 Proceedings of the National Academy of Sciences of the United States of America PMC19916 9520446
  10. [12]Tergaonkar V Bottero V Ikawa M Li Q Verma IM IkappaB kinase-independent IkappaBalpha degradation pathway: functional NF-kappaB activity and implications for cancer therapy Mol Cell Biol 2003 23 8070 83 14585967 PMC262380
  11. [13]Aoki M Batista O Bellacosa A Tsichlis P Vogt PK The Akt kinase: Molecular determinants of oncogenicity Proc.Natl.Acad.Sci.USA 1998 95 14950 5 9843996 PMC24556
  12. [14]Vogt PK Habel K Salzman NP Focus assay of Rous sarcoma virus Fundamental Techniques in Virology 1969 198 211 Academic Press New York First ed.
  13. [15]Federspiel MJ Hughes SH Retroviral gene delivery Methods Cell Biol 1997 52 179 214 9379950
  14. [16]Bader AG Felts KA Jiang N Chang HW Vogt PK Y box-binding protein 1 induces resistance to oncogenic transformation by the phosphatidylinositol 3-kinase pathway Proc Natl Acad Sci U S A 2003 100 12384 9 14530393 PMC218767
  15. [17]Maki Y Bos TJ Davis C Starbuck M Vogt PK Avian sarcoma virus 17 carries the jun oncogene Proc Natl Acad Sci U S A 1987 84 2848 52 3033666 PMC304757
  16. [18]Duff RG Vogt PK Characteristics of two new avian tumor virus subgroups Virology 1969 39 18 30 4309068
  17. [19]Aoki M Schetter C Himly M Batista O Chang HW Vogt PK The catalytic subunit of phosphoinositide 3-kinase: requirements for oncogenicity J Biol Chem 2000 275 6267 75 10692423
  18. [20]Bos TJ Monteclaro FS Mitsunobu F Ball AR Chang CH Nishimura T Vogt PK Efficient transformation of chicken embryo fibroblasts by c-Jun requires structural modification in coding and noncoding sequences Genes & Development 1990 4 1677 87 2123464
  19. [21]Chang HW Aoki M Fruman D Auger KR Bellacosa A Tsichlis PN Cantley LC Roberts TM Vogt PK Transformation of Chicken Cells by the Gene Encoding the Catalytic Subunit of PI 3-Kinase Science 1997 276 1848 50 9188528
  20. [22]Madrid LV Wang CY Guttridge DC Schottelius AJ Baldwin AS Jr. Mayo MW Akt suppresses apoptosis by stimulating the transactivation potential of the RelA/p65 subunit of NF-kappaB Mol Cell Biol 2000 20 1626 38 10669740 PMC85346
  21. [23]Kau TR Schroeder F Ramaswamy S Wojciechowski CL Zhao JJ Roberts TM Clardy J Sellers WR Silver PA A chemical genetic screen identifies inhibitors of regulated nuclear export of a Forkhead transcription factor in PTEN-deficient tumor cells Cancer Cell 2003 4 463 76 14706338
  22. [24]Yang L Dan HC Sun M Liu Q Sun XM Feldman RI Hamilton AD Polokoff M Nicosia SV Herlyn M Sebti SM Cheng JQ Akt/protein kinase B signaling inhibitor-2, a selective small molecule inhibitor of Akt signaling with antitumor activity in cancer cells overexpressing Akt Cancer Res 2004 64 4394 9 15231645
  23. [25]Wu G Xing M Mambo E Huang X Liu J Guo Z Chatterjee A Goldenberg D Gollin S Sukumar S Trink B Sidransky D Somatic mutation and gain of copy number of PIK3CA in human breast cancer Breast Cancer Research 2005 7 R609 R16 16168105 PMC1242128
  24. [26]McKinsey TA Brockman JA Scherer DC Al-Murrani SW Green PL Ballard DW Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1: a potential mechanism for constitutive induction of NF-kappaB Mol Cell Biol 1996 16 2083 90 8628274 PMC231195
  25. [27]Karin M Cao Y Greten FR Li ZW NF-kappaB in cancer: from innocent bystander to major culprit Nat Rev Cancer 2002 2 301 10 12001991
  26. [28]Campbell KJ Perkins ND Post-translational modification of RelA(p65) NF-kappaB Biochem Soc Trans 2004 32 1087 9 15506973
  27. [30]Hou S Guan H Ricciardi RP Phosphorylation of serine 337 of NF-kappaB p50 is critical for DNA binding J Biol Chem 2003 278 45994 8 12947093
  28. [31]Guan H Hou S Ricciardi RP DNA binding of repressor nuclear factor-kappaB p50/p50 depends on phosphorylation of Ser337 by the protein kinase A catalytic subunit J Biol Chem 2005 280 9957 62 15642694
  29. [32]Zhong H Voll RE Ghosh S Phosphorylation of NF-kappa B p65 by PKA stimulates transcriptional activity by promoting a novel bivalent interaction with the coactivator CBP/p300 Mol Cell 1998 1 661 71 9660950
  30. [33]Wang D Westerheide SD Hanson JL Baldwin AS Jr. Tumor necrosis factor alpha-induced phosphorylation of RelA/p65 on Ser529 is controlled by casein kinase II J Biol Chem 2000 275 32592 7 10938077
  31. [34]Sakurai H Chiba H Miyoshi H Sugita T Toriumi W IkappaB kinases phosphorylate NF-kappaB p65 subunit on serine 536 in the transactivation domain J Biol Chem 1999 274 30353 6 10521409
  32. [35]Mayo MW Madrid LV Westerheide SD Jones DR Yuan XJ Baldwin AS Jr. Whang YE PTEN blocks tumor necrosis factor-induced NF-kappa B-dependent transcription by inhibiting the transactivation potential of the p65 subunit J Biol Chem 2002 277 11116 25 11799112
  33. [36]Hu MC Lee DF Xia W Golfman LS Ou-Yang F Yang JY Zou Y Bao S Hanada N Saso H Kobayashi R Hung MC IkappaB kinase promotes tumorigenesis through inhibition of forkhead FOXO3a Cell 2004 117 225 37 15084260
  34. [37]Buss H Dorrie A Schmitz ML Hoffmann E Resch K Kracht M Constitutive and interleukin-1-inducible phosphorylation of p65 NF-{kappa}B at serine 536 is mediated by multiple protein kinases including I{kappa}B kinase (IKK)-{alpha}, IKK{beta}, IKK{epsilon}, TRAF family member-associated (TANK)-binding kinase 1 (TBK1), and an unknown kinase and couples p65 to TATA-binding protein-associated factor II31-mediated interleukin-8 transcription J Biol Chem 2004 279 55633 43 15489227
  35. [38]Lawrence T Bebien M Liu GY Nizet V Karin M IKKalpha limits macrophage NF-kappaB activation and contributes to the resolution of inflammation Nature 2005 434 1138 43 15858576
  36. [39]Buss H Dorrie A Schmitz ML Hoffmann E Resch K Kracht M Constitutive and Interleukin-1-inducible Phosphorylation of p65 NF-{kappa}B at Serine 536 Is Mediated by Multiple Protein Kinases Including I{kappa}B Kinase (IKK)-{alpha}, IKK{beta}, IKK{epsilon}, TRAF Family Member-associated (TANK)-binding Kinase 1 (TBK1), and an Unknown Kinase and Couples p65 to TATA-binding Protein-associated Factor II31-mediated Interleukin-8 Transcription J. Biol. Chem 2004 279 55633 43 15489227
  37. [40]Schmitz M dos Santos Silva M Altmann H Czisch M Holak T Baeuerle P Structural and functional analysis of the NF-kappa B p65 C terminus. An acidic and modular transactivation domain with the potential to adopt an alpha-helical conformation J. Biol. Chem 1994 269 25613 20 7929265
  38. [41]Sizemore N Lerner N Dombrowski N Sakurai H Stark GR Distinct roles of the Ikappa B kinase alpha and beta subunits in liberating nuclear factor kappa B (NF-kappa B) from Ikappa B and in phosphorylating the p65 subunit of NF-kappa B J Biol Chem 2002 277 3863 9 11733537
  39. [42]Yang F Tang E Guan K Wang CY IKK beta plays an essential role in the phosphorylation of RelA/p65 on serine 536 induced by lipopolysaccharide J Immunol 2003 170 5630 5 12759443
  40. [43]Delhase M Li N Karin M Kinase regulation in inflammatory response Nature 2000 406 367 8 10935625
  41. [44]Takada Y Fang X Jamaluddin MS Boyd DD Aggarwal BB Genetic deletion of glycogen synthase kinase-3beta abrogates activation of IkappaBalpha kinase, JNK, Akt, and p44/p42 MAPK but potentiates apoptosis induced by tumor necrosis factor J Biol Chem 2004 279 39541 54 15252041
  42. [45]Ghosh S Tergaonkar V Rothlin CV Correa RG Bottero V Bist P Verma IM Hunter T Essential role of tuberous sclerosis genes TSC1 and TSC2 in NF-kappaB activation and cell survival Cancer Cell 2006 10 215 26 16959613
  43. [46]Dan HC Baldwin AS Differential involvement of IkappaB kinases alpha and beta in cytokine- and insulin-induced mammalian target of rapamycin activation determined by Akt J Immunol 2008 180 7582 9 18490760
  44. [47]Dan HC Cooper MJ Cogswell PC Duncan JA Ting JP Baldwin AS Akt-dependent regulation of NF-{kappa}B is controlled by mTOR and Raptor in association with IKK Genes Dev 2008 22 1490 500 18519641 PMC2418585
  45. [48]Baldwin AS Control of oncogenesis and cancer therapy resistance by the transcription factor NF-kappaB J Clin Invest 2001 107 241 6 11160144 PMC199203
  46. [49]Huber MA Azoitei N Baumann B Grunert S Sommer A Pehamberger H Kraut N Beug H Wirth T NF-kappaB is essential for epithelial-mesenchymal transition and metastasis in a model of breast cancer progression J Clin Invest 2004 114 569 81 15314694 PMC503772
  47. [50]Wilhelmsen KC Eggleton K Temin HM Nucleic acid sequences of the oncogene v-rel in reticuloendotheliosis virus strain T and its cellular homolog, the proto-oncogene c-rel J Virol 1984 52 172 82 6090694 PMC254503
  48. [51]Gilmore TD Multiple mutations contribute to the oncogenicity of the retroviral oncoprotein v-Rel Oncogene 1999 18 6925 37 10602467
  49. [52]Pikarsky E Porat RM Stein I Abramovitch R Amit S Kasem S Gutkovich-Pyest E Urieli-Shoval S Galun E Ben-Neriah Y NF-kappaB functions as a tumour promoter in inflammation-associated cancer Nature 2004 431 461 6 15329734
  50. [53]Luo JL Maeda S Hsu LC Yagita H Karin M Inhibition of NF-kappaB in cancer cells converts inflammation- induced tumor growth mediated by TNFalpha to TRAIL-mediated tumor regression Cancer Cell 2004 6 297 305 15380520
  51. [54]Greten FR Eckmann L Greten TF Park JM Li ZW Egan LJ Kagnoff MF Karin M IKKbeta links inflammation and tumorigenesis in a mouse model of colitis-associated cancer Cell 2004 118 285 96 15294155

Cited by

Sorted by citations

Authors
Bai, D., Ueno, L., & Vogt, P. K.
Affiliations
Scripps Research Institute (US)
Corresponding author
Vogt, Peter K.
Venue
International Journal of Cancer
Publisher
Wiley
Published
2009-09
Volume
125
Issue
12
Pages
2863-2870
ISSN
  • 0020-7136 (ISSN-L)
  • 1097-0215
OpenAlex
W1965627667
Cited by
529
References
3
Citations by year
2026: 25 · 2025: 48 · 2024: 50 · 2023: 48 · 2022: 37 · 2021: 61 · 2020: 44 · 2019: 39 · 2018: 41 · 2017: 39 · 2016: 20 · 2015: 21 · 2014: 16 · 2013: 7 · 2012: 8
FWCI
3.69
Type
journal article
Language
en
Open access
Locations
  • International Journal of Cancer (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
Funders
National Cancer Institute (R01CA078230, P01CA078045)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › NF-κB Signaling Pathways
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Signaling Pathways in Disease
Keywords
Akt, NF-κB, phosphatidylinositol 3-kinase, oncogenic transformation, IκB degradation, p65 phosphorylation, IkappaB kinase alpha, IκB kinase β, chicken embryo fibroblasts, transcriptional regulation, AKT inhibitors
MeSH terms
Animals, Cell Nucleus, Cell Transformation, Neoplastic, Chick Embryo, Fibroblasts, Gene Expression Regulation, Luciferases, Phosphorylation, Transcription, Genetic, Blotting, Western, Signal Transduction, NF-kappa B, Phosphatidylinositol 3-Kinases, Immunoprecipitation, Proto-Oncogene Proteins c-akt, Mice, I-kappa B Kinase

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review